BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.०१०
०.००%
(०.००) 1D
नोभेम्बर ९, १६:१२:०५ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
२.७६ करोड
Avg. vol.
९९.६८ लाख
Volume
२६.९१ लाख
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
२.७६ करोड
Avg. vol.
९९.६८ लाख
Volume
२६.९१ लाख
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
News stories
From web sources and news partners
New York Post
·
१ घण्टा पहिले
Dow surges 1,000 points after last week’s historic tech rout, while Jensen Huang’s Nvidia slumps
TradingView
·
५९ मिनेट पहिले
Avalanche: Secures clearing and settlement role for NYSE-affiliated platform - 09 Nov 2026
24/7 Wall St.
·
१२ मिनेट पहिले
Verizon’s Dividends Kept $1,000 Afloat at $1,580 While the S&P 500 Reached $3,910
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd